Masatsugu Okishiro

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim et al. · Cancer · 2009 · 121 citations · Full text

MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide

Masatsugu Okishiro, Seung Jin Kim, Ryo Tsunashima et al. · Breast Cancer Research and Treatment · 2011 · 26 citations

Breast Oncology, Breast Cancer Patients, Medicine +8

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi et al. · Journal of Cancer Research and Clinical Oncology · 2007 · 12 citations · Full text

Breast Oncology, Oncology, Low Nuclear Grade +10

Topoisomerase IIalpha-positive and BRCA1-negative phenotype: Association with favorable response to epirubicin-based regimens for human breast cancers

Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi et al. · Cancer Letters · 2008 · 12 citations

Breast Oncology, Oncology, Endocrine-related Cancer +11

Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole

Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim et al. · Journal of Cancer Research and Clinical Oncology · 2008 · 10 citations · Full text

Bone Disease, Joint Symptoms, Breast Cancer +5